GENE ONLINE|News &
Opinion
Blog

Mirati Therapeutics
GeneOnline’s Weekly News Highlights: Oct 8-Oct 13
2023-10-17
Day 3 ESMO 2021 Roundup: Mirati’s KRAS Drug Surpasses Amgen’s in Colorectal Cancer Trial
2021-09-20
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Amgen’s KRAS G12C Inhibitor Impresses in Phase 2 NSCLC Trial
2020-10-09
R&D
Unveiling of KRAS Inhibitor Clinical Data Initiates Mirati, Amgen comparisons
2019-10-29
LATEST
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
EVENT
Scroll to Top